These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 24305700)
21. LMR-101, a novel derivative of propofol, exhibits potent anticonvulsant effects and possibly interacts with a novel target on γ-aminobutyric acid type A receptors. Zhao Y; An L; Guo S; Huang X; Tian H; Liu L; Chen T; Sun X; Mei Q; Wang R Epilepsia; 2021 Jan; 62(1):238-249. PubMed ID: 33417274 [TBL] [Abstract][Full Text] [Related]
22. Clustering of spontaneous recurrent seizures separated by long seizure-free periods: An extended video-EEG monitoring study of a pilocarpine mouse model. Lim JA; Moon J; Kim TJ; Jun JS; Park B; Byun JI; Sunwoo JS; Park KI; Lee ST; Jung KH; Jung KY; Kim M; Jeon D; Chu K; Lee SK PLoS One; 2018; 13(3):e0194552. PubMed ID: 29558523 [TBL] [Abstract][Full Text] [Related]
24. Effects of LY379268, a selective group II metabotropic glutamate receptor agonist on EEG activity, cortical perfusion, tissue damage, and cortical glutamate, glucose, and lactate levels in brain-injured rats. Stover JF; Sakowitz OW; Beyer TF; Dohse NK; Kroppenstedt SN; Thomale UW; Schaser KD; Unterberg AW J Neurotrauma; 2003 Apr; 20(4):315-26. PubMed ID: 12866811 [TBL] [Abstract][Full Text] [Related]
25. The metabotropic glutamate receptor 5 antagonist MPEP and the mGluR2 agonist LY379268 modify disease progression in a transgenic mouse model of Huntington's disease. Schiefer J; Sprünken A; Puls C; Lüesse HG; Milkereit A; Milkereit E; Johann V; Kosinski CM Brain Res; 2004 Sep; 1019(1-2):246-54. PubMed ID: 15306259 [TBL] [Abstract][Full Text] [Related]
26. Group II metabotropic glutamate receptor activation by agonist LY379268 treatment increases the expression of brain derived neurotrophic factor in the mouse brain. Di Liberto V; Bonomo A; Frinchi M; Belluardo N; Mudò G Neuroscience; 2010 Feb; 165(3):863-73. PubMed ID: 19909793 [TBL] [Abstract][Full Text] [Related]
27. 2-Deoxyglucose terminates pilocarpine-induced status epilepticus in neonatal rats. Janicot R; Stafstrom CE; Shao LR Epilepsia; 2020 Jul; 61(7):1528-1537. PubMed ID: 32558935 [TBL] [Abstract][Full Text] [Related]
28. The effect of ((-)-2-oxa-4-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY379268), an mGlu2/3 receptor agonist, on EEG power spectra and coherence in ketamine model of psychosis. Fujáková M; Páleníček T; Brunovský M; Gorman I; Tylš F; Kubešová A; Řípová D; Krajča V; Horáček J Pharmacol Biochem Behav; 2014 Jul; 122():212-21. PubMed ID: 24631484 [TBL] [Abstract][Full Text] [Related]
29. Differential changes in mGlu2 and mGlu3 gene expression following pilocarpine-induced status epilepticus: a comparative real-time PCR analysis. Ermolinsky B; Pacheco Otalora LF; Arshadmansab MF; Zarei MM; Garrido-Sanabria ER Brain Res; 2008 Aug; 1226():173-80. PubMed ID: 18585369 [TBL] [Abstract][Full Text] [Related]
30. Preferential effects of the metabotropic glutamate 2/3 receptor agonist LY379268 on conditioned reinstatement versus primary reinforcement: comparison between cocaine and a potent conventional reinforcer. Baptista MA; Martin-Fardon R; Weiss F J Neurosci; 2004 May; 24(20):4723-7. PubMed ID: 15152032 [TBL] [Abstract][Full Text] [Related]
31. Metabotropic glutamate receptor 8 in the rat hippocampus after pilocarpine induced status epilepticus. Tang FR; Lee WL; Yang J; Sim MK; Ling EA Neurosci Lett; 2001 Mar; 300(3):137-40. PubMed ID: 11226630 [TBL] [Abstract][Full Text] [Related]
32. Behavioral and functional evidence of metabotropic glutamate receptor 2/3 and metabotropic glutamate receptor 5 dysregulation in cocaine-escalated rats: factor in the transition to dependence. Hao Y; Martin-Fardon R; Weiss F Biol Psychiatry; 2010 Aug; 68(3):240-8. PubMed ID: 20416862 [TBL] [Abstract][Full Text] [Related]
34. Progression of convulsive and nonconvulsive seizures during epileptogenesis after pilocarpine-induced status epilepticus. Smith ZZ; Benison AM; Bercum FM; Dudek FE; Barth DS J Neurophysiol; 2018 May; 119(5):1818-1835. PubMed ID: 29442558 [TBL] [Abstract][Full Text] [Related]
35. Chronic treatment with a metabotropic mGlu2/3 receptor agonist diminishes behavioral response to a phenethylamine hallucinogen. Halberstadt AL; van der Zee JVF; Chatha M; Geyer MA; Powell SB Psychopharmacology (Berl); 2019 Feb; 236(2):821-830. PubMed ID: 30448990 [TBL] [Abstract][Full Text] [Related]
36. Early polytherapy for benzodiazepine-refractory status epilepticus. Niquet J; Lumley L; Baldwin R; Rossetti F; Schultz M; de Araujo Furtado M; Suchomelova L; Naylor D; Franco-Estrada I; Wasterlain CG Epilepsy Behav; 2019 Dec; 101(Pt B):106367. PubMed ID: 31636007 [TBL] [Abstract][Full Text] [Related]
37. Loss of metabotropic glutamate receptor-dependent long-term depression via downregulation of mGluR5 after status epilepticus. Kirschstein T; Bauer M; Müller L; Rüschenschmidt C; Reitze M; Becker AJ; Schoch S; Beck H J Neurosci; 2007 Jul; 27(29):7696-704. PubMed ID: 17634364 [TBL] [Abstract][Full Text] [Related]
38. Glycine release is regulated by metabotropic glutamate receptors sensitive to mGluR2/3 ligands and activated by N-acetylaspartylglutamate (NAAG). Romei C; Raiteri M; Raiteri L Neuropharmacology; 2013 Mar; 66():311-6. PubMed ID: 22659408 [TBL] [Abstract][Full Text] [Related]
39. Effects of noninvasive transcutaneous electrical stimulation via concentric ring electrodes on pilocarpine-induced status epilepticus in rats. Besio WG; Koka K; Cole AJ Epilepsia; 2007 Dec; 48(12):2273-9. PubMed ID: 17651415 [TBL] [Abstract][Full Text] [Related]
40. Pharmacological profiling of native group II metabotropic glutamate receptors in primary cortical neuronal cultures using a FLIPR. Sanger H; Hanna L; Colvin EM; Grubisha O; Ursu D; Heinz BA; Findlay JD; Vivier RG; Sher E; Lodge D; Monn JA; Broad LM Neuropharmacology; 2013 Mar; 66():264-73. PubMed ID: 22659090 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]